Xue-Ying Li (Xueying Li)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Acute Lymphoblastic Leukemia

Tyrosine Kinase

Newly Diagnosed

Top Venues

American journal of hematology

British journal of haematology

Clinics (Sao Paulo, Brazil)

This page only lists publications with an associated author ORCID identifier.

Publications

De Zhou, Xianbo Huang, Mixue Xie, Lixia Zhu, Xin Huang, Xue-Ying Li, Xiudi Yang, Li Li, Jingjing Zhu, Xiaolong Zheng, Jianai Sun, Shuqi Zhao, Wenjuan Yu, Wanzhuo Xie, Hong-Yan Tong, Jie Jin, Hong Hu Zhu, Xiu-Jin Ye
Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial. American journal of hematology (2023)
Mixue Xie, Ying Lu, Guifang Ouyang, Xue-Ying Li, Ting Shi, Min Yang, Jing Le, Huixian Hu, Li Zhang, Weiying Feng, Haitao Meng, Wenyuan Mai, Juying Wei, Jiejing Qian, Gaixiang Xu, Chunmei Yang, De Zhou, Yin Lin, Suying Qian, Yuemin Kuang, Liming Zhang, Weiguo Zhu, Guoli Yao, Gongqiang Wu, Shao Hu, Xin Huang, Yungui Wang, Hong-Yan Tong, Jie Jin, Hong Hu Zhu
Dasatinib plus prednisone as induction and consolidation for adults with Ph-positive acute lymphoblastic leukaemia: A single-arm, multicentre, phase 2 trial. British journal of haematology (2023)
De Zhou, Xianbo Huang, Mixue Xie, Lixia Zhu, Xin Huang, Xue-Ying Li, Xiudi Yang, Li Li, Jingjing Zhu, Xiaolong Zheng, Jianai Sun, Shuqi Zhao, Wenjuan Yu, Wanzhuo Xie, Hong-Yan Tong, Jie Jin, Hong Hu Zhu, Xiu-Jin Ye
Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial. American journal of hematology (2023)
Huan-Ping Wang, Yile Zhou, Xin Huang, Yi Zhang, Jiejing Qian, Jianhu Li, Chenying Li, Xue-Ying Li, Yinjun Lou, Qiaoyun Zhu, Yujie Huang, Haitao Meng, Wenjuan Yu, Hong-Yan Tong, Jie Jin, Hong-Hu Zhu
Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T-cell acute lymphoblastic leukaemia. British journal of haematology 193 (6) (2021)
Ting Shi, Huan-Ping Wang, Mixue Xie, Xue-Ying Li, Lixia Zhu, Xiu-Jin Ye
Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era. Clinics (Sao Paulo, Brazil) 75 (2020)
Huan-Ping Wang, Yi-Le Zhou, Xin Huang, Yi Zhang, Jie-Jing Qian, Jian-Hu Li, Xue-Ying Li, Chen-Ying Li, Yin-Jun Lou, Wen-Yuan Mai, Hai-Tao Meng, Wen-Juan Yu, Hong-Yan Tong, Jie Jin, Hong Hu Zhu
CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia. American journal of hematology 96 (3) (2020)
Xue-Ying Li, Jie-Jing Qian, Min Yang, Yi Zhang, Sha-Sha Wang, Hai-Tao Meng, Wen-Juan Yu, Hong-Yan Tong, Xiu-Jin Ye, Jie Jin, Hong-Hu Zhu
An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia. British journal of haematology 189 (6) (2020)